BE-101 Poultry Biologic Advances Toward USDA Licensure
GREENFIELD, INDIANA, UNITED STATES — February 18, 2026 BiomEdit has initiated the pivotal field safety trial for its lead...
antimicrobial resistance
Advertisement
smartbax In-Licenses Novel Gram-Negative Antibiotic From Aicuris
MUNICH, Germany, January 20, 2026 — smartbax, a biotechnology company focused on next-generation antibiotics, announced the in-licensing of a...
ShanX Medtech Secures €24M to Advance Ultra-Rapid AMR Diagnostics
EINDHOVEN, The Netherlands | January 7, 2026 — ShanX Medtech announced the successful close of a €24 million financing...
Positive Zoliflodacin Phase 3 Data Published in The Lancet
LONDON, December 12, 2025 — Innoviva Specialty Therapeutics announced the publication of positive Phase 3 clinical results for zoliflodacin...
InnotiveDx Secures £1M PACE Grant for Rapid UTI Test
BATH, England — November 26, 2025. Innotive Diagnostics (InnotiveDx) has been awarded a £1 million grant from PACE, one...
Advertisements
Armata Announces Phase 2a Success for S. aureus Phage Therapy
Los Angeles, CA – October 22, 2025 — Armata Pharmaceuticals, Inc., a biotechnology company advancing bacteriophage-based therapeutics, announced positive...
Biotia Launches Advanced “Test to Treat” for Recurrent UTIs
NEW YORK, September 8, 2025 — Biotia has introduced an innovative “test to treat” pathway for patients suffering from...
Advertisement
